Can-Fite BioPharma Ltd.CANFEarnings & Financial Report
NYSE
CANF Q2 2025 Key Financial Metrics
Revenue
$202.0K
Gross Profit
N/A
Operating Profit
$-4.9M
Net Profit
$-4.9M
Gross Margin
N/A
Operating Margin
-2424.8%
Net Margin
-2413.9%
YoY Growth
-36.1%
EPS
$0.00
Financial Flow
Can-Fite BioPharma Ltd. Q2 2025 Financial Summary
Can-Fite BioPharma Ltd. reported revenue of $202.0K (down 36.1% YoY) for Q2 2025, with a net profit of $-4.9M (down 23.2% YoY) (-2413.9% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $202.0K |
|---|---|
| Net Profit | $-4.9M |
| Gross Margin | N/A |
| Operating Margin | -2424.8% |
| Report Period | Q2 2025 |
Can-Fite BioPharma Ltd. Quarterly Revenue & Net Profit History
Can-Fite BioPharma Ltd. quarterly results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 2025 | $202.0K | -36.1% | $-4.9M | -2413.9% |
| Q2 2024 | $316.0K | -19.4% | $-4.0M | -1252.2% |
Income Statement
| Q2 2024 | Q2 2025 | |
|---|---|---|
| Revenue | $316000 | $202000 |
| YoY Growth | -19.4% | -36.1% |
Balance Sheet
| Q2 2024 | Q2 2025 | |
|---|---|---|
| Assets | $5.9M | $7.7M |
| Liabilities | $3.4M | $3.5M |
| Equity | $2.5M | $4.2M |
Cash Flow
| Q2 2024 | Q2 2025 | |
|---|---|---|
| Operating CF | $-4.0M | $-4.8M |